Stroke remains the number one cause of disability in the adult population. Despite scientific progress in our understanding of stroke pathology, only one treatment (tissue plasminogen activator or tPA) is able to afford benefits but to less than 3% of ischemic stroke patients. The development of experimental dietary supplement therapeutics designed to stimulate endogenous mechanisms that confer neuroprotection is likely to open new avenues for exploring stroke therapies. The present review article evaluates the recent literature supporting the benefits of dietary supplementation for the therapy of ischemic stroke. This article focuses on discussing the medical benefits of NT-020 as an adjunct agent for stroke therapy. Based on our preliminary data, a pre-stroke treatment with dietary supplementation promotes neuroprotection by decreasing inflammation and enhancing neurogenesis. However, we recognize that a pre-stroke treatment holds weak clinical relevance. Thus, the main goal of this article is to provide information about recent data that support the assumption of natural compounds as neuroprotective and to evaluate the therapeutic effects of a dietary supplement called NT-020 as in a stroke model. We focus on a systematic assessment of practical treatment parameters so that NT-020 and other dietary supplementations can be developed as an adjunct agent for the prevention or treatment of chronic diseases. We offer rationale for determining the optimal dosage, therapeutic window, and mechanism of action of NT-020 as a dietary supplement to produce neuroprotection when administered immediately after stroke onset. We highlight our long-standing principle in championing both translational and basic science approaches in an effort to fully reveal the therapeutic potential of NT-020 as dietary supplementation in the treatment of stroke. We envision dietary supplementation as an adjunct therapy for stroke at acute, subacute, and even chronic periods.
References
[1]
Wolf, P.A.; Cobb, J.L.; D’Agostino, R.B. Epidemiology of Stroke. In Stroke: Pathophysiology, Diagnosis, and Management; Barnett, H.J., Stein, B.M., Mohr, J.P., Yatsu, F.M., Eds.; Churchill Livingstone: New York, NY, USA, 1992; pp. 3–27.
[2]
Moskowitz, M.A.; Lo, E.H.; Ladecola, C. The science of stroke: Mechanisms in search of treatments. Neuron 2010, 67, 181–198.
[3]
Acosta, S.; Jernberg, J.; Sanberg, C.D.; Sanberg, P.R.; Small, B.J.; Gemma, C.; Bickford, P.C. NT-020, a natural therapeutic approach to optimize spatial memory performance and increase neural progenitor cell proliferation and decrease inflammation in the aged rat. Rejuvenation Res 2010, 13, 581–588.
[4]
Wang, X.; Qin, X.; Demirtas, H. Efficacy of folic acid supplementation in stroke prevention: A meta-analysis. Lancet 2007, 369, 1876–1882.
[5]
Arab, L.; Liebeskind, D.S. Tea, flavonoids and stroke in man and mouse. Arch. Biochem. Biophys 2010, 501, 31–36.
[6]
Bachstetter, A.D.; Jernberg, J.; Schlunk, A.; Vila, J.L.; Hudson, C. Spirulina promotes stem cell genesis and protects against LPS induced declines in neural stem cell proliferation. PLoS One 2010, 5, doi:10.1371/journal.pone.0010496.
[7]
Zavala-Alarcon, E.; Cecena, F.; Ashar, R.; Patel, R.; van Poppel, S.; Carlson, R. Safety of elective—Including “high risk”—Percutaneous coronary interventions without on-site cardiac surgery. Am. Heart J 2004, 148, 676–683.
[8]
Reynolds, B.A.; Weiss, S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255, 1707–1710.
[9]
Duan, W.; Guo, Z.; Jiang, H.; Ware, M.; Mattson, M.P. Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology 2003, 144, 2446–2453.
[10]
Joseph, J.A.; Shukitt-Hale, B.; Denisova, N.A.; Bielinski, D.; Martin, A.; McEwen, J.J.; Bickford, P.C. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J. Neurosci 1999, 19, 8114–8121.
[11]
Dupret, D.; Revest, J.-M.; Koehl, M.; Ichas, F.; de Giorgi, F. Spatial relational memory requires hippocampal adult neurogenesis. PLoS One 2008, 3, doi:10.1371/journal.pone.0001959.
[12]
Vukovic, J.; Blackmore, D.G.; Jhaveri, D.; Bartlett, P.F. Activation of neural precursors in the adult neurogenic niches. Neurochem. Int 2011, 59, 341–346.
[13]
Borlongan, C.V.; Glover, L.E.; Tajiri, N.; Kaneko, Y.; Freeman, T.B. The great migration of bone marrow-derived stem cells toward the ischemic brain: Therapeutic implications for stroke and other neurological disorders. Prog. Neurobiol 2011, 95, 213–228.
[14]
Borlongan, C.V. Bone marrow stem cell mobilization in stroke: A “bonehead” may be good after all! Leukemia 2011, 25, 1674–1686.
Haas, S.; Weidner, N.; Winkler, J. Adult stem cell therapy in stroke. Curr. Opin. Neurol 2005, 18, 59–64.
[17]
Picard-Riera, N.; Nait-Oumesmar, B.; Baron-van Evercooren, A. Endogenous adult neural stem cells: Limits and potential to repair the injured central nervous system. J. Neurosci. Res 2004, 15, 76, 223–231.
[18]
Bachstetter, A.D.; Pabon, M.M.; Cole, M.J.; Hudson, C.E.; Sanberg, P.R.; Willing, A.E.; Bickford, P.C.; Gemma, C. Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain. BMC Neurosci 2008, 9, doi:10.1186/1471–2202-9-22.
[19]
Bickford, P.C.; Tan, J.; Shytle, R.D.; Sanberg, C.D.; El-Badri, N.; Sanberg, P.R. Nutraceuticals synergistically promote proliferation of human stem cells. Stem Cells Dev 2006, 15, 118–123.
[20]
Vendrame, M.; Gemma, C.; de Mesquita, D.; Collier, L.; Bickford, P.C.; Sanberg, C.D.; Sanberg, P.R.; Pennypacker, K.R.; Willing, A.E. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 2005, 14, 595–604.
[21]
Yasuhara, T.; Hara, K.; Maki, M.; Masuda, T.; Sanberg, C.D.; Sanberg, P.R.; Bickford, P.C.; Borlongan, C.V. Dietary supplementation exerts neuroprotective effects in ischemic stroke model. Rejuvenation Res 2008, 11, 201–214.
[22]
Jones, N.E.; Heyland, D.K. Pharmaconutrition: A new emerging paradigm. Curr. Opin. Gastroenterol 2008, 24, 215–222.
[23]
Joseph, J.A.; Shukitt-Hale, B.; Casadesus, G. Reversing the deleterious effects of aging on neuronal communication and behavior: Beneficial properties of fruit polyphenolic compounds. Am. J. Clin. Nutr 2005, 81, 313S–316S.
[24]
Valente, T.; Hidalgo, J.; Bolea, I.; Ramirez, B.; Angles, N.; Reguant, J.; Morello, J.R.; Gutierrez, C.; Boada, M.; Unzeta, M. A diet enriched in polyphenols and polyunsaturated fatty acids, LMN diet, induces neurogenesis in the subventricular zone and hippocampus of adult mouse brain. J. Alzheimers Dis. 2009, 18, 849–865.
[25]
Venna, V.R.; Deplanque, D.; Allet, C.; Belarbi, K.; Hamdane, M.; Bordet, R. PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology 2009, 34, 199–211.
[26]
Ahmet, I.; Wan, R.; Mattson, M.P.; Lakatta, E.G.; Talan, M. Cardioprotection by intermittent fasting in rats. Circulation 2005, 112, 3115–3121.
[27]
Anson, R.M.; Guo, Z.; de Cabo, R.; Iyun, T.; Rios, M.; Hagepanos, A.; Ingram, D.K.; Lane, M.A.; Mattson, M.P. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc. Natl. Acad. Sci. USA 2003, 100, 6216–6220.
[28]
Mattson, M.P.; Duan, W.; Guo, Z. Meal size and frequency affect neuronal plasticity and vulnerability to disease: Cellular and molecular mechanisms. J. Neurochem 2003, 84, 417–431.
[29]
Mattson, M.P.; Duan, W.; Wan, R.; Guo, Z. Prophylactic activation of neuroprotective stress response pathways by dietary and behavioral manipulations. NeuroRx 2004, 1, 111–116.
[30]
Yu, Z.F.; Mattson, M.P. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: Evidence for a preconditioning mechanism. J. Neurosci. Res 1999, 57, 830–839.
Casadesus, G.; Shukitt-Hale, B.; Stellwagen, H.M.; Zhu, X.; Lee, H.G.; Smith, M.A.; Joseph, J.A. Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr. Neurosci 2004, 7, 309–316.
[33]
Bazan, H.A.; Lu, Y.; Thoppil, D.; Fitzgerald, T.N.; Hong, S.; Dardik, A. Diminished omega-3 fatty acids are associated with carotid plaques from neurologically symptomatic patients: Implications for carotid interventions. Vasc. Pharmacol 2009, 51, 331–336.
[34]
Blondeau, N.; Nguemeni, C.; Debruyne, D.N.; Piens, M.; Wu, X.; Pan, H.; Hu, X.; Gandin, C.; Lipsky, R.H.; Plumier, J.C.; Marini, A.M.; Heurteaux, C. Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: A versatile potential therapy for stroke. Neuropsychopharmacology 2009, 34, 2548–2559.
[35]
Zheng, G.Q.; Cheng, W.; Wang, Y.; Wang, X.M.; Zhao, S.Z.; Zhou, Y. Ginseng total saponins enhance neurogenesis after focal cerebral ischemia. J. Ethnopharmacol 2011, 133, 724–728.
[36]
Morse, D.; Choi, A.M. Heme oxygenase-1: From bench to bedside. Am. J. Respir. Crit. Care Med 2005, 172, 660–670.
[37]
Saleem, S.; Zhuang, H.; Biswal, S.; Christen, Y.; Dore, S. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 2008, 39, 3389–3396.
[38]
Maswood, N.; Young, J.; Tilmont, E.; Zhang, Z.; Gash, D.M.; Gerhardt, G.A.; Grondin, R.; Roth, G.S.; Mattison, J.; Lane, M.A.; et al. Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson’s disease. Proc. Natl. Acad. Sci. USA 2004, 101, 18171–18176.
[39]
Mattson, M.P. The need for controlled studies of the effects of meal frequency on health. Lancet 2005, 365, 1978–1980.
[40]
Borlongan, C.V.; Hadman, M.; Sanberg, C.D.; Sanberg, P.R. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004, 35, 2385–2389.
[41]
Borlongan, C.V.; Lind, J.G.; Dillon-Carter, O.; Yu, G.; Hadman, M.; Cheng, C.; Carroll, J.; Hess, D.C. Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res 2004, 1010, 108–116.
[42]
Langdon, K.D.; Clarke, J.; Corbett, D. Long-term exposure to high fat diet is bad for your brain: Exacerbation of focal ischemic brain injury. Neuroscience 2011, 182, 82–87.
[43]
Puig, K.L.; Floden, A.M.; Adhikari, R.; Golovko, M.Y.; Combs, C.K. Amyloid precursor protein and proinflamatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity. PLoS One 2012, 7, doi:10.1371/journal.pone.0030378.
[44]
Stromberg, I.; Gemma, C.; Vila, J.; Bickford, P.C. Blueberry- and spirulina-enriched diets enhance striatal dopamine recovery and induce a rapid, transient microglia activation after injury of the rat nigrostriatal dopamine system. Exp. Neurol 2005, 196, 298–307.
[45]
Borlongan, C.V.; Lind, J.G.; Dillon-Carter, O.; Yu, G.; Hadman, M.; Cheng, C.; Carroll, J.; Hess, D.C. Intracerebral xenografts of mouse bone marrow cells in adult rats facilitate restoration of cerebral blood flow and blood-brain barrier. Brain Res 2004, 1009, 26–33.
[46]
Borlongan, C.V.; Lind, J.G.; Dillon-Carter, O.; Yu, G.; Hadman, M.; Cheng, C.; Carroll, J.; Hess, D.C. Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res 2004, 1010, 108–116.
[47]
Borlongan, C.V.; Yamamoto, M.; Takei, N.; Kumazaki, M.; Ungsuparkorn, C.; Hida, H.; Sanberg, P.R.; Nishino, H. Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia. FASEB J 2000, 14, 1307–1317.
[48]
Beech, J.S.; Reckless, J.; Mosedale, D.E.; Grainger, D.J.; Williams, S.C.; Menon, D.K. Neuroprotection in ischemia-reperfusion injury: An antiinflammatory approach using a novel broad-spectrum chemokine inhibitor. J. Cereb. Blood Flow Metab 2001, 21, 683–689.
[49]
Ito, D.; Tanaka, K.; Suzuki, S.; Dembo, T.; Fukuuchi, Y. Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 2001, 32, 1208–1215.
[50]
Marks, L.; Carswell, H.V.; Peters, E.E.; Graham, D.I.; Patterson, J.; Dominiczak, A.F.; Macrae, I.M. Characterization of the microglial response to cerebral ischemia in the stroke-prone spontaneously hypertensive rat. Hypertension 2001, 38, 116–122.
[51]
Wang, X.; Qin, X.; Demirtas, H. Efficacy of folic acid supplementation in stroke prevention: A meta-analysis. Lancet 2007, 369, 1876–1882.
[52]
Kahles, T.; Luedike, P.; Endres, M.; Galla, H.J.; Steinmetz, H.; Busse, R.; Neumann-Haefelin, T.; Brandes, R.P. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 2007, 38, 3000–3006.
[53]
Lenzsér, G.; Kis, B.; Snipes, J.A.; Gáspár, T.; Sándor, P.; Komjáti, K.; Szabó, C.; Busija, D.W. Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats. J. Cereb. Blood Flow Metab 2007, 27, 1318–1326.
[54]
Hamby, A.M.; Suh, S.W.; Kauppinen, T.M.; Swanson, R.A. Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion. Stroke 2007, 38, 632–636.
[55]
Kauppinen, T.M.; Suh, S.W.; Berman, A.E.; Hamby, A.M.; Swanson, R.A. Inhibition of poly(ADP-ribose) polymerase suppresses inflammation and promotes recovery after ischemic injury. J. Cereb. Blood Flow Metab 2009, 29, 820–829.
[56]
Garbuzova-Davis, S.; Haller, E.; Saporta, S.; Kolomey, I.; Nicosia, S.V.; Sanberg, P.R. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res 2007, 1157, 126–137.
[57]
Garbuzova-Davis, S.; Sanberg, C.D.; Kuzmin-Nichols, N.; Willing, A.E.; Gemma, C.; Bickford, P.C.; Miller, C.; Rossi, R.; Sanberg, P.R. Human umbilical cord blood treatment in a mouse model of ALS: Optimization of cell dose. PLoS One 2008, 3, doi:10.1371/journal.pone.0002494.
[58]
Garbuzova-Davis, S.; Saporta, S.; Haller, E.; Kolomey, I.; Bennett, S.P.; Potter, H.; Sanberg, P.R. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One 2007, 2, doi:10.1371/journal.pone.0001205.
[59]
Zhu, Y.; Bickford, P.C.; Sanberg, P.; Giunta, B.; Tan, J. Blueberry opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activation protein kinase. Rejuvenation Res 2008, 11, 891–901.
[60]
Borlongan, C.V.; Tajima, Y.; Trojanowski, J.Q.; Lee, V.M.; Sanberg, P.R. Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp. Neurol 1998, 149, 310–321.
[61]
Borlongan, C.V.; Chopp, M.; Steinberg, G.K.; Bliss, T.M.; Li, Y.; Lu, M.; Hess, D.C.; Kondziolka, D. Potential of stem/progenitor cells in treating stroke: The missing steps in translating cell therapy from laboratory to clinic. Regen. Med 2008, 3, 249–250.
[62]
Stem Cell Therapies as an Emerging Paradigm in Stroke Participants. Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): Bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke 2009, 40, 510–515.
